We recently published a list of 10 Firms End Friday Strong; 3 Reach All-Time Highs. In this article, we are going to take a ...

The filing is based on late-stage data, which shows that treatment with the subcutaneous version of MRK's Keytruda is at ...

Merck & Co. Inc. closed 33.72% short of its 52-week high of $134.63, which the company achieved on June 25th.

In the latest trading session, Merck (MRK) closed at $89.23, marking a +1.86% move from the previous day. This move outpaced the S&P 500's daily loss of 1.97%. Meanwhile, the Dow experienced a drop of ...

Within that group, biotechnology giant Amgen (NASDAQ: AMGN) has been the best-performing stock in 2025, returning an ...

Lululemon Athletica and Oxford Industries both warned that consumer spending is slowing. Merck anticipates putting an ...

The interleukin-2 (IL-2) therapies market in the USA is poised for major growth, projected to reach $4 billion by 2034, ...

Vanguard Health Care ETF (VHT) is rated a hold due to high valuations and low profitability of top holdings despite strong ...

Discover whether AbbVie or Sanofi holds the edge in the global immunology market and find out which stock shows more ...

Major indices were in the early on Friday as market participants digested the Federal Reserve's preferred inflation measure.

San Francisco Federal Reserve Bank President Mary Daly still sees two interest-rate cuts this year as a "reasonable" ...

With President Donald Trump expected to levy tariffs on pharmaceuticals manufactured outside the United States, industry ...